Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alx Oncology Holdings Inc
(NQ:
ALXO
)
7.660
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
7.660
Bid (Size)
4.100 (10)
Ask (Size)
9.040 (1)
Prev. Close
7.660
Today's Range
7.660 - 7.660
52wk Range
3.936 - 17.82
Shares Outstanding
40,869,135
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer
June 02, 2024
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference
May 29, 2024
From
ALX Oncology
Via
GlobeNewswire
Performance
YTD
-47.35%
-47.35%
1 Month
+3.79%
+3.79%
3 Month
-52.36%
-52.36%
6 Month
-45.09%
-45.09%
1 Year
+10.53%
+10.53%
More News
Read More
ALXO Stock Earnings: ALX Oncology Holdings Beats EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 09, 2024
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Holdings Inc. (NASDAQ: ALXO) Leading the Way in Friday Trading Based on Percentage Gain
December 08, 2023
Via
Investor Brand Network
ALX Oncology Appoints Allison Dillon as Chief Business Officer
May 07, 2024
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces Initiation of Phase 2 Investigator-Sponsored Trial of Neoadjuvant Radiation and Evorpacept in Combination with Pembrolizumab in Patients with Untreated HPV-Mediated Oropharyngeal Cancer
April 30, 2024
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting
April 24, 2024
From
ALX Oncology
Via
GlobeNewswire
Where ALX Oncology Holdings Stands With Analysts
December 08, 2023
Via
Benzinga
The Latest Analyst Ratings for ALX Oncology Holdings
November 14, 2023
Via
Benzinga
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 17, 2024
Via
Benzinga
United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday
April 17, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
ALX Oncology Reports Encouraging Clinical Data of Evorpacept in Combination with Standard-of-Care in an Ongoing Phase 1/2 Clinical Trial in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (“R/R B-NHL”)
April 09, 2024
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Has 'Elevated Valuation' - Analyst Downgrades Stock, Highlights Need For Development De-Risking Beyond Gastric Cancer
March 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 08, 2024
Via
Benzinga
ALXO Stock Earnings: ALX Oncology Holdings Beats EPS for Q4 2023
March 07, 2024
Via
InvestorPlace
ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 07, 2024
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology Announces Two Evorpacept Clinical Abstracts Accepted for Presentation at the AACR Annual Meeting
March 05, 2024
From
ALX Oncology
Via
GlobeNewswire
ALX Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
ALX Oncology
Via
GlobeNewswire
7 Small-Cap Stocks That Wall Street Loves for Good Reason
December 22, 2023
Via
InvestorPlace
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 22, 2023
Via
Benzinga
Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday
December 22, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Comtech Telecommunications Shares Are Trading Lower By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 08, 2023
Via
Benzinga
Torrid Reports Upbeat Results, Joins MBIA, Virco Mfg. And Other Big Stocks Moving Higher On Friday
December 08, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.